Medgend Icon

Ledgend of Medicine







discontinued


Vivelle

Infertility means not being able to get pregnant after at least one year of trying (or 6 months if the woman is over age 35). If a woman keeps having miscarriages, it is also called infertility. Female infertility can result from age, physical problems, hormone problems, and lifestyle or environmental factors.

Most cases of infertility in women result from problems with producing eggs. In primary ovarian insufficiency, the ovaries stop functioning before natural menopause. In polycystic ovary syndrome (PCOS), the ovaries may not release an egg regularly or they may not release a healthy egg.

About a third of the time, infertility is because of a problem with the woman. One third of the time, it is a problem with the man. Sometimes no cause can be found.

If you think you might be infertile, see your doctor. There are tests that may tell if you have fertility problems. When it is possible to find the cause, treatments may include medicines, surgery, or assisted reproductive technologies. Happily, many couples treated for infertility are able to have babies.

Dept. of Health and Human Services Office on Women's Health

Vivelle FDA Approved Drugs

ALORA [EstradiolC18H24O2]
RX
-
0.025mg/24hr (transdermal film, extended release)
0.05mg/24hr (transdermal film, extended release)
0.075mg/24hr (transdermal film, extended release)
0.1mg/24hr (transdermal film, extended release)
Allergan Sales LlcApr 5, 2002
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CLIMARA [EstradiolC18H24O2]
RX
-
0.025mg/24hr (transdermal film, extended release)
0.0375mg/24hr (transdermal film, extended release)
0.05mg/24hr (transdermal film, extended release)
0.06mg/24hr (transdermal film, extended release)
0.075mg/24hr (transdermal film, extended release)
0.1mg/24hr (transdermal film, extended release)
Bayer HlthcareMar 5, 1999
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIVIGEL [EstradiolC18H24O2]
RX
-
0.1% (0.25gm/packet) (transdermal gel)
0.1% (0.5gm/packet) (transdermal gel)
0.1% (1gm/packet) (transdermal gel)
Vertical Pharms LlcJun 4, 2007
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ELESTRIN [EstradiolC18H24O2]
RX
-
0.06% (0.87gm/activation) (transdermal gel, metered)
Mylan Speciality LpDec 15, 2006
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ESTRACE [EstradiolC18H24O2]
RX
-
0.01% (vaginal cream)
Allergan Sales LlcJan 31, 1984
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ESTRADIOL [EstradiolC18H24O2]
RX
-
0.025mg/24hr (transdermal film, extended release)
0.0375mg/24hr (transdermal film, extended release)
0.05mg/24hr (transdermal film, extended release)
0.06mg/24hr (transdermal film, extended release)
0.075mg/24hr (transdermal film, extended release)
0.1mg/24hr (transdermal film, extended release)
0.5mg (oral tablet)
10mcg (vaginal tablet)
2mg (oral tablet)
Mylan TechnologiesDec 19, 2014
Barr Labs IncOct 22, 1997
Epic Pharma IncDec 29, 1998
Mayne PharmaMar 14, 1996
Amneal PharmsMay 29, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ESTRING [EstradiolC18H24O2]
RX
-
0.0075mg/24hr (vaginal insert, extended release)
Pharmacia And UpjohnApr 26, 1996
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ESTROGEL [EstradiolC18H24O2]
RX
-
0.06% (1.25gm/activation) (transdermal gel, metered)
Ascend Theraps UsFeb 9, 2004
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

EVAMIST [EstradiolC18H24O2]
RX
-
1.53mg/spray (transdermal spray)
Perrigo Pharma IntlJul 27, 2007
  • Female hormone replacement therapy for postmenopausal women.
  • Menopausal and postmenopausal disorders (including vasomotor symptoms associated with menopause).
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MENOSTAR [EstradiolC18H24O2]
RX
-
0.014mg/24hr (transdermal film, extended release)
Bayer HlthcareJun 8, 2004
  • Prevention of postmenopausal osteoporosis.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MINIVELLE [EstradiolC18H24O2]
RX
-
0.025mg/24hr (transdermal film, extended release)
0.0375mg/24hr (transdermal film, extended release)
0.05mg/24hr (transdermal film, extended release)
0.075mg/24hr (transdermal film, extended release)
0.1mg/24hr (transdermal film, extended release)
NovenSep 23, 2014
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VAGIFEM [EstradiolC18H24O2]
RX
-
10mcg (vaginal tablet)
Novo Nordisk IncNov 25, 2009
  • Treatment of atrophic vaginitis due to menopause.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VIVELLE-DOT [EstradiolC18H24O2]
RX
-
0.025mg/24hr (transdermal film, extended release)
0.0375mg/24hr (transdermal film, extended release)
0.05mg/24hr (transdermal film, extended release)
0.075mg/24hr (transdermal film, extended release)
0.1mg/24hr (transdermal film, extended release)
NovartisMay 3, 2002
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.